Article Correctness Is Author's Responsibility: C-Path and Lundbeck enter collaboration to advance drug development tools in Alzheimer’s

(Critical Path Institute (C-Path)) C-Path and Lundbeck are proud to announce that they will work together to significantly improve the scientific community's insight in Alzheimer's disease through Lundbeck's contribution of a unique set of clinical trial data from more than 2,500 patients to the Critical Path for Alzheimer's Disease consortium's integrated database for qualified researchers across the globe to access.